Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cytomegalovirus immune globulin (human)
Drug ID BADD_D00562
Description Cytomegalovirus immunoglobulin is obtained from pooled adult human plasma selected for high titers of antibody for cytomegalovirus (CMV). It contains purified immunoglobulin G (IgG) antibodies targeting cytomegalovirus (CMV)[FDA label]. Cytomegalovirus, a member of the herpes virus family, is ubiquitous the human population, leading to infections which are followed by life-long dormancy in the host with occasional reactivations and recurrent infections. The seroprevalence of antibodies in adults ranges from 40-100 % with an inverse correlation to socioeconomic status. The transmission of cytomegalovirus infection requires intimate contact with infected excretions such as saliva, urine, cervical and vaginal excretions, semen, breast milk and blood [L2228]. CMV infection can lead to a high fever and severe organ-specific damage with significant morbidity and mortality rates. Cytomegalovirus (CMV) may lead to a wide spectrum of infection in immunocompetent hosts. Sites most often involved include the lung (severe community-acquired viral pneumonia), liver (transaminitis), spleen (splenomegaly), GI tract (colitis), CNS (encephalitis), the hematologic system (cytopenias), and multisystem involvement [L2230]. During the span of an individual's life, the virus may reactivate, resulting in repeated shedding and spread of the virus. Molecular mechanisms have been identified by which show that CMVs interfere with the host immune system. Finally, however, the infection is normally controlled by the host's immune response. As a consequence, CMV disease is restricted to the immunocompromised or immunologically immature host, in which it can lead the devastating result of transplant rejection [A32498], [L2229].
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID DB13886
KEGG ID Not Available
MeSH ID C045781
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code 44206-532
Synonyms cytomegalovirus-specific hyperimmune globulin | cytomegalovirus immunoglobulin intravenous (human) | human cytomegalovirus immune globulin | CMV immunoglobulin | CMV-immune globulin | CMVIG | Cytogam | cytotect
Chemical Information
Molecular Formula Not Available
CAS Registry Number 339086-15-6
SMILES Not Available
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Acute respiratory distress syndrome22.01.03.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Apnoea22.02.01.001--
Arthralgia15.01.02.001--
Back pain15.03.04.005--
Blood pressure decreased13.14.03.002--Not Available
Bronchospasm22.03.01.004; 10.01.03.012--
Cardiac arrest02.03.04.001--
Chills15.05.03.016; 08.01.09.001--
Circulatory collapse24.06.02.001--Not Available
Coma17.02.09.001--Not Available
Coombs direct test13.01.01.006--Not Available
Cyanosis24.03.01.007; 22.02.02.007; 02.01.02.002--
Dermatitis bullous23.03.01.002--
Dyspnoea02.01.03.002; 22.02.01.004--
Erythema multiforme23.03.01.003; 10.01.03.015--
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Haemolysis01.06.04.002--
Hepatic function abnormal09.01.02.001--Not Available
Hypotension24.06.03.002--
Hypoxia22.02.02.003--
Leukopenia01.02.02.001--Not Available
Loss of consciousness17.02.04.004--Not Available
Muscle spasms15.05.03.004--
Nausea07.01.07.001--
Nephrotic syndrome20.05.01.002--
Pancytopenia01.03.03.003--Not Available
Pulmonary oedema22.01.03.003; 02.05.02.003--
The 1th Page    1 2    Next   Last    Total 2 Pages